Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Princess Margaret Hospital and University of Toronto, Canada

Name: Princess Margaret Hospital and University of Toronto, Canada
Uploaded: 2008-11-28T00:00:00+00:00
Description: Sunitinib vs. interferon-alfa as first-line treatment for metastatic renal cancer, from ESMO 2008

ESMO 33

12 - 16 Sep 2008

Published: 28 Nov 2008

Rating:

Save

Prof. Ian Tannock

Sunitinib vs. interferon-alfa as first-line treatment for metastatic renal cancer, from ESMO 2008

Categories:
Prostate & urology

Related Videos

Laser oncosurgery - A new perspective in treating cancer

Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India

24 Oct 2024

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

16 Sep 2024

ESMO 2024: Latest in bladder cancer - expert review

Dr Patrizia Giannatempo, Prof Andrea Necchi, Prof Simon Crabb, Dr Michiel Van Der Heijden

16 Sep 2024

Understanding the use of PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard

15 Sep 2024

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

15 Sep 2024

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

14 Sep 2024

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

10 Sep 2024

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

7 Sep 2024

Princess Margaret Hospital and University of Toronto, Canada

ESMO 33

Related Videos

More from ecancer